Home › Stocks › LIXT

LIXT — LIXTE BIOTECHNOLOGY HLDGS IN

Reported value held$177.28K
Funds holding (latest)10
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

LIXT (LIXTE BIOTECHNOLOGY HLDGS IN) is tracked on HoldingsHub across five years of quarterly 13F filings. 10 funds have reported positions historically, with the sum of their latest reported stakes valued at $177.28K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

Major shareholders of LIXTE BIOTECHNOLOGY HLDGS IN (LIXT) include Geode Capital Management, Morgan Stanley, Vanguard Group, ranked by reported 13F value among the 10 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q2 2023 3 17.33K $101.37K -90.5%
Q1 2023 6 240.68K $199.39K +16.1%
Q4 2022 8 218.33K $110.61K -26.6%
Q3 2022 7 297.19K $166.00K +14.5%
Q2 2022 7 289.44K $216.00K -8.9%
Q1 2022 4 203.30K $248.00K +3.5%
Q4 2021 4 196.43K $234.00K +3.1%
Q3 2021 4 190.56K $396.00K +4.8%

Over the 8 quarters shown, institutional share counts decreased 91% in aggregate (Q3 2021 → Q2 2023); the largest single-quarter swing was Q4 2022 (-26.6%).

Top Institutional Holders (Q2 2023) — 3 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 10.12K $58.99K 0.00% Reduce
Morgan Stanley 7.11K $41.78K 0.00% Reduce
UBS Group AG 101 $594 0.00% Reduce

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q1 2023 — 6 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 101.21K $84.00K 0.00% Add
Morgan Stanley 71.05K $58.78K 0.00% Hold
Vanguard Group 32.74K $27.09K 0.00% Reduce
Two Sigma Investments 24.90K $20.60K 0.00% Add
UBS Group AG 10.72K $8.87K 0.00% Add
Wells Fargo & Co 53 $44 0.00% Add

Q4 2022 — 8 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 81.13K $41.30K 0.00% Hold
Morgan Stanley 71.05K $36.17K 0.00% Hold
Geode Capital Management 25.79K $13.00K 0.00% Hold
Two Sigma Investments 19.87K $10.12K 0.00% Reduce
Renaissance Technologies 10.60K $5.00K 0.00% Reduce
UBS Group AG 9.47K $4.83K 0.00% Add
Bank of America Corp 348 $178 0.00% New
Wells Fargo & Co 52 $26 0.00% New

Q3 2022 — 7 funds

FundSharesValuePortfolio WeightChange
Renaissance Technologies 90.66K $51.00K 0.00% Add
Vanguard Group 81.13K $45.00K 0.00% Reduce
Morgan Stanley 71.05K $40.00K 0.00% Hold
Geode Capital Management 25.79K $14.00K 0.00% Hold
Two Sigma Investments 21.27K $12.00K 0.00% Add
UBS Group AG 7.17K $4.00K 0.00% Add
Fidelity Management & Research (FMR) 100 $0 — New

Q2 2022 — 7 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 83.96K $62.00K 0.00% Hold
Morgan Stanley 71.05K $53.00K 0.00% Hold
Renaissance Technologies 57.19K $43.00K 0.00% New
Citadel Advisors 30.06K $23.00K 0.00% New
Geode Capital Management 25.79K $19.00K 0.00% Reduce
Two Sigma Investments 16.95K $13.00K 0.00% New
UBS Group AG 4.44K $3.00K 0.00% Reduce

Q1 2022 — 4 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 83.96K $103.00K 0.00% Add
Morgan Stanley 71.05K $87.00K 0.00% Hold
Geode Capital Management 40.97K $49.00K 0.00% Add
UBS Group AG 7.32K $9.00K 0.00% Reduce

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 10 funds)

FundQ2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Geode Capital Management 10.12K 101.21K 25.79K 25.79K 25.79K 40.97K 40.66K 37.52K —
Morgan Stanley 7.11K 71.05K 71.05K 71.05K 71.05K 71.05K 71.05K 71.05K —
UBS Group AG 101 10.72K 9.47K 7.17K 4.44K 7.32K 7.51K 4.04K —
Renaissance Technologies — — 10.60K 90.66K 57.19K — — — 50.90K
Wells Fargo & Co — 53 52 — — — — — —
Bank of America Corp — — 348 — — — — — —
Vanguard Group — 32.74K 81.13K 81.13K 83.96K 83.96K 77.21K 77.95K 74.38K
Citadel Advisors — — — — 30.06K — — — —
Fidelity Management & Research (FMR) — — — 100 — — — — —
Two Sigma Investments — 24.90K 19.87K 21.27K 16.95K — — — —

Download holders (CSV)

FAQ

Which funds hold LIXT?

10 funds have reported positions in LIXT across five years of 13F filings; the sum of their latest reported stakes is $177.28K.

Who are the top institutional holders of LIXT?

The largest 13F holders are Geode Capital Management, Morgan Stanley, Vanguard Group, Citadel Advisors, Two Sigma Investments; the top 25 are ranked at the top of this page.

Who are the major shareholders of LIXTE BIOTECHNOLOGY HLDGS IN?

The major shareholders of LIXTE BIOTECHNOLOGY HLDGS IN (LIXT) by reported 13F value are Geode Capital Management, Morgan Stanley, Vanguard Group, Citadel Advisors, Two Sigma Investments, among 10 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own LIXT" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/LIXT/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →